Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Results of Intensive Chemotherapy in 434 Adult Patients (pts) with Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL): Predictive Prognostic Model for Survival

Musa Yilmaz, MD, Hagop M. Kantarjian, MD, Jorge Cortes, Guillermo Garcia-Manero, MD, Jad Chahoud, MD, Farhad Ravandi, MD, Koji Sasaki, MD, Marina Konopleva, MD PhD, Koichi Takahashi, MD, William G. Wierda, Nitin Jain, MD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Elias Jabbour

Blood (2015) 126 (23): 3722.

https://doi.org/10.1182/blood.V126.23.3722.3722

Published: 2015

Journal Articles

The W–x–x–W Motif in the TSR1 of ADAMTS13 Is Important for Its Secretion

Jing Ling, Jian Su, Zhenni Ma, Changgeng Ruan, MD, PhD

Blood (2012) 120 (21): 4389.

https://doi.org/10.1182/blood.V120.21.4389.4389

Published: 2012

Journal Articles

Complement alternative pathway acts as a positive feedback amplification of neutrophil activation

Laurent Camous, Lubka Roumenina, Sylvain Bigot, Soumeya Brachemi, Véronique Frémeaux-Bacchi, Philippe Lesavre, Lise Halbwachs-Mecarelli

Blood (2011) 117 (4): 1340–1349.

https://doi.org/10.1182/blood-2010-05-283564

Published: 2011

Journal Articles

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2010) 116 (21): 3572.

https://doi.org/10.1182/blood.V116.21.3572.3572

Published: 2010

Journal Articles

Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement

Yuko Kimura, Takashi Miwa, Lin Zhou, Wen-Chao Song

Blood (2008) 111 (2): 732–740.

https://doi.org/10.1182/blood-2007-05-089821

Published: 2008

Journal Articles

Successful Induction of a Rapid Improvement of Both Clinical and Laboratory Parameters in a Patient with Advanced CLL by Combining Rituximab with Fresh Frozen Plasma as a Source for Complement. A Novel Therapeutic Approach?.

Abraham Klepfish, MD, H. Ghoti, MD, E.A. Rachmilewitz, MD

Blood (2005) 106 (11): 5030.

https://doi.org/10.1182/blood.V106.11.5030.5030

Published: 2005

NARROW

Results of Intensive Chemotherapy in 434 Adult Patients (pts) with Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL): Predictive Prognostic Model for Survival

The W–x–x–W Motif in the TSR1 of ADAMTS13 Is Important for Its Secretion

Complement alternative pathway acts as a positive feedback amplification of neutrophil activation

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement

Successful Induction of a Rapid Improvement of Both Clinical and Laboratory Parameters in a Patient with Advanced CLL by Combining Rituximab with Fresh Frozen Plasma as a Source for Complement. A Novel Therapeutic Approach?.

Email alerts

ASH Publications

American Society of Hematology

Results of Intensive Chemotherapy in 434 Adult Patients (pts) with Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL): Predictive Prognostic Model for Survival

The W–x–x–W Motif in the TSR1 of ADAMTS13 Is Important for Its Secretion

Complement alternative pathway acts as a positive feedback amplification of neutrophil activation

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement

Successful Induction of a Rapid Improvement of Both Clinical and Laboratory Parameters in a Patient with Advanced CLL by Combining Rituximab with Fresh Frozen Plasma as a Source for Complement. A Novel Therapeutic Approach?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only